Alnylam Discusses RNAi Delivery

Aug 24, 2011
By BioPharm International Editors

Alnylam Pharmcaeuticals, a company specializing in RNA-interference therapeutics, talks to BioPharm International's Amy Ritter about its RNAi delivery system and its early-stage clinical pipeline.